×
Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    North America Cell Line Development Market Forecast 2027 By Source (Mammalian, Non-mammalian {Insects, Amphibians}), By Product (Reagents & Media, Equipment {Incubator, Centrifuge, Bioreactor, Storage Equipment, Microscope}, Accessories & Consumables), By Cell Line (Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line), By Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: September 2021   |   Report ID: GR1067   |   Delivery: PDF  Request Free Sample

    Report Content

    Chapter 1   Methodology

    1.1    Methodology

    1.2    Market definitions

    1.3    Forecast parameters

    1.4    Data sources

    1.4.1    Secondary

    1.4.1.1    Paid sources

    1.4.1.2    Unpaid sources

    1.4.2    Primary

    Chapter 2   Executive Summary

    2.1    North America cell line development market industry 3600 synopsis, 2016 - 2027

    Chapter 3   North America Cell Line Development Market Industry Insights

    3.1    Industry segmentation

    3.2    Industry landscape, 2016 - 2027

    3.3    Industry impact forces

    3.3.1    Growth drivers

    3.3.1.1    Growing vaccine production

    3.3.1.2    Increasing cancer prevalence

    3.3.1.3    Growth in biotechnology industry

    3.3.1.4    Innovations in biologics due to patent expirations

    3.3.1.5    Rising demand for monoclonal antibodies

    3.3.1.6    Technological innovation in cell line development

    3.3.2    Industry pitfalls & challenges

    3.3.2.1    Issues related to stem cell research

    3.4    COVID-19 impact analysis

    3.5    Competitive review, 2020

    3.5.1    Strategy dashboard

    3.6    Porter’s analysis

    3.7    PEST analysis

    Chapter 4   North America Cell Line Development Market, By Product

    4.1    Key segment trends

    4.2    Reagents and media

    4.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    4.3    Equipment

    4.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    4.3.2    Incubators

    4.3.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    4.3.3    Centrifuges

    4.3.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    4.3.4    Bioreactors

    4.3.4.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    4.3.5    Storage equipment

    4.3.5.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    4.3.6    Microscopes

    4.3.6.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    4.4    Accessories & consumables

    4.4.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    Chapter 5   North America Cell Line Development Market, By Source

    5.1    Key segment trends

    5.2    Mammalian

    5.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    5.3    Non-mammalian

    5.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    5.3.2    Insects

    5.3.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    5.3.3    Amphibians

    5.3.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    Chapter 6   North America Cell Line Development Market, By Cell Line Type

    6.1    Key segment trends

    6.2    Recombinant cell lines

    6.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    6.3    Hybridomas

    6.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    6.4    Continuous cell lines

    6.4.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    6.5    Primary cell lines

    6.5.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    Chapter 7   North America Cell Line Development Market, By Application

    7.1    Key segment trends

    7.2    Bioproduction

    7.2.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    7.3    Drug discovery

    7.3.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    7.4    Toxicity testing

    7.4.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    7.5    Tissue engineering

    7.5.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    7.6    Research

    7.6.1    Market estimates and forecast, by country, 2016 - 2027 (USD Million)

    Chapter 8   North America Cell Line Development Market, By Country

    8.1    Key country trends

    8.2    North America

    8.2.1    Market estimates and forecast by country, 2016 - 2027 (USD Million)

    8.2.2    Market estimates and forecast by product, 2016 - 2027 (USD Million)

    8.2.3    Market estimates and forecast by source, 2016 - 2027 (USD Million)

    8.2.4    Market estimates and forecast by cell line type, 2016 - 2027 (USD Million)

    8.2.5    Market estimates and forecast by application, 2016 - 2027 (USD Million)

    8.2.6    U.S.

    8.2.6.1    Market estimates and forecast by product, 2016 - 2027 (USD Million)

    8.2.6.2    Market estimates and forecast by source, 2016 - 2027 (USD Million)

    8.2.6.3    Market estimates and forecast by cell line type, 2016 - 2027 (USD Million)

    8.2.6.4    Market estimates and forecast by application, 2016 - 2027 (USD Million)

    8.2.7    Canada

    8.2.7.1    Market estimates and forecast by product, 2016 - 2027 (USD Million)

    8.2.7.2    Market estimates and forecast by source, 2016 - 2027 (USD Million)

    8.2.7.3    Market estimates and forecast by cell line type, 2016 - 2027 (USD Million)

    8.2.7.4    Market estimates and forecast by application, 2016 - 2027 (USD Million)

    Chapter 9   Company Profiles

    9.1    GE Healthcare

    9.1.1    Business overview

    9.1.2    Financial data

    9.1.3    Product landscape

    9.1.4    Strategic outlook

    9.2    Thermo Fisher Scientific Inc.

    9.2.1    Business overview

    9.2.2    Financial data

    9.2.3    Product landscape

    9.2.4    Strategic outlook

    9.3    Lonza Group AG

    9.3.1    Business overview

    9.3.2    Financial data

    9.3.3    Product landscape

    9.3.4    Strategic outlook

    9.4    Sigma-Aldrich Corporation (Merck)

    9.4.1    Business overview

    9.4.2    Financial data

    9.4.3    Product landscape

    9.4.4    Strategic outlook

    9.5    WuXi AppTec

    9.5.1    Business overview

    9.5.2    Financial data

    9.5.3    Product landscape

    9.5.4    Strategic outlook

    9.6    Sartorius Stedim Biotech GmbH

    9.6.1    Business overview

    9.6.2    Financial data

    9.6.3    Product landscape

    9.6.4    Strategic outlook

    9.7    Corning Inc.

    9.7.1    Business overview

    9.7.2    Financial data

    9.7.3    Product landscape

    9.7.4    Strategic outlook

    9.8    Selexis SA

    9.8.1    Business overview

    9.8.2    Financial data

    9.8.3    Product landscape

    9.8.4    Strategic outlook

    9.9    GVK BIO

    9.9.1    Business overview

    9.9.2    Financial data

    9.9.3    Product landscape

    9.9.4    Strategic outlook

    9.10    Vista Biologicals

    9.10.1    Business overview

    9.10.2    Financial data

    9.10.3    Product landscape

    9.10.4    Strategic outlook
     


    Get this research report on North America Cell Line Development Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

      (+1)-208-273-9852

     [email protected]